Skip to main content

Table 2 Comparison between urolithiasis and non-urolithiasis groups

From: Association between sleep quality and urolithiasis among general population in Western China: a cross-sectional study

Variable

Urolithiasis

Standardize diff.

P-value*

No, N = 30,233,N(%)

Yes, N = 4204, N(%)

PSQI grouping

  

0.073 (0.041, 0.106)

< 0.001

 <=7

21,530 (71.214%)

2852 (67.840%)

  

 > 7

8703 (28.786%)

1352 (32.160%)

  

Subjective sleep quality

  

0.073 (0.041, 0.106)

< 0.001

 0

5205 (17.216%)

697 (16.579%)

  

 1

18,076 (59.789%)

2410 (57.326%)

  

 2

5771 (19.088%)

922 (21.931%)

  

 3

1181 (3.906%)

175 (4.163%)

  

Sleep latency

  

0.072 (0.040, 0.104)

< 0.001

 0

7679 (25.399%)

1013 (24.096%)

  

 1

6830 (22.591%)

875 (20.814%)

  

 2

10,181 (33.675%)

1445 (34.372%)

  

 3

5543 (18.334%)

871 (20.718%)

  

Sleep duration

  

0.060 (0.028, 0.093)

0.004

 0

9219 (30.493%)

1182 (28.116%)

  

 1

14,503 (47.971%)

2043 (48.597%)

  

 2

3900 (12.900%)

570 (13.559%)

  

 3

2611 (8.636%)

409 (9.729%)

  

Habitual sleep efficiency

  

0.060 (0.027, 0.092)

0.004

 0

13,855 (45.827%)

1840 (43.768%)

  

 1

6617 (21.887%)

896 (21.313%)

  

 2

3895 (12.883%)

561 (13.344%)

  

 3

5866 (19.403%)

907 (21.575%)

  

Sleep disturbance

  

0.098 (0.066, 0.131)

< 0.001

 0

4127 (13.651%)

479 (11.394%)

  

 1

22,971 (75.980%)

3182 (75.690%)

  

 2

3041 (10.059%)

526 (12.512%)

  

 3

94 (0.311%)

17 (0.404%)

  

Use of sleep medication

  

0.011 (−0.021, 0.043)

0.938

 0

29,224 (96.663%)

4067 (96.741%)

  

 1

334 (1.105%)

46 (1.094%)

  

 2

251 (0.830%)

31 (0.737%)

  

 3

424 (1.402%)

60 (1.427%)

  

Daytime dysfunction

  

0.106 (0.074, 0.138)

< 0.001

 0

23,076 (76.327%)

3027 (72.003%)

  

 1

4289 (14.186%)

679 (16.151%)

  

 2

2081 (6.883%)

340 (8.088%)

  

 3

787 (2.603%)

158 (3.758%)

  
  1. % for Categorical variables: P-value* was calculated by chi -square test